Revolutionizing AI: AWS and NVIDIA Forge Path to Future

Cutting-Edge Supercomputing and Drug Discovery Technologies

AWS and NVIDIA have significantly expanded their strategic collaboration, as announced at AWS re:Invent. This partnership aims to provide advanced infrastructure, software, and services for generative AI innovations. Key aspects of this collaboration include:

1. NVIDIA GH200 Grace Hopper Superchips on AWS: AWS is the first cloud provider to offer these superchips, enabling scalability to thousands of GH200 Superchips for supercomputer-class performance.
2. NVIDIA DGX Cloud on AWS: This AI-training-as-a-service will feature GH200 NVL32 for accelerated training of generative AI and large language models.
3. Project Ceiba: This project aims to design the world’s fastest GPU-powered AI supercomputer with 16,384 NVIDIA GH200 Superchips, achieving a processing capability of 65 exaflops.
4. New Amazon EC2 Instances: AWS introduces three new EC2 instances, including P5e instances powered by NVIDIA H200 Tensor Core GPUs for large-scale generative AI and HPC workloads.
5. Software Innovations: NVIDIA introduces software on AWS, like NeMo Retriever microservice for chatbots and summarisation tools, and BioNeMo to accelerate drug discovery for pharmaceutical companies.

This collaboration signifies a commitment to advancing generative AI, offering cutting-edge technologies and resources. The integration of NVIDIA and AWS technologies will enhance the development, training, and inference of large language models and generative AI applications across various industries​​.